Abstract
Testosterone is used in the gender transition process by transmasculine people and, although considered safe, may increase cardiovascular risk for this population. In pathophysiological contexts, testosterone exerts deleterious effects in the cardiovascular system, but its effects on PVAT, especially in the gender-affirming hormone therapy, are not known. Considering that immune system ce…